Stanford Antimicrobial Safety & Sustainability Program @StanfordASP

Joined June 2009
Great session at #IDWeek24 with our very own at @StanDeresinski discussing challenging diagnostic cases in ID ⭐️ cc: @Stanford_ID @IDWeekmtg @IDSAInfo @SHEA_Epi @PIDSociety @SIDPharm
1
1
27
1,187
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience ✅ Just Accepted 🔓 Open Access 🔗 bit.ly/3OTb8OF @DHpharmd @jessicawithID @Pharm_Bean @EmilyMui @StanDeresinski @Marisa_Holubar @Willeeuhmm
9
29
3,365
Invasive mucormycosis is an uncommon infix that has been associated with high rates of mortality. Differences in pt host factors, dx presentation, and mgmt practices have made it difficult to ascertain efficacy of interventions with invasive mucormycosis. @MAD_ID_ASP #MADID2023
11
17
2,155
So proud of our one and only Dr. David Ha discussing antimicrobial stewardship in intraabdominal infections @DHpharmd @Stanford_Med_ID #SHEASpring2023
2
8
26
2,542
Emily Mui retweeted
So proud of our ⭐ brilliant ⭐ @Stanford_ID fellows @AlexZimmet @RalphTayyarMD and Krithi Srinivasan presenting research at #SHEASpring2023! Rock stars! 🤩
1
8
1
32
3,841
📢 We are proud to announce the launch of our Outpatient Antibiotic Guidebook! 💊📖 #IDTwitter #MedEd @StanfordDeptMed @StanfordMed @StanfordHealth @Stanford_ID @Stanford_Med_ID med.stanford.edu/bugsanddrug…
33
3
72
6,594
Emily Mui retweeted
A daily thought of mine is how spoiled we are with such amazing ID fellows, ♥️ you folks! ☺️ @Stanford_ID @Stanford_Med_ID
1
1
27
2,074
Emily Mui retweeted
📢 Poll Question In liver transplant recipients, what duration of abx surgical ppx does your institution recommend? Feel free to comment below if you provide diff recs based on patient-specific factors (MELD, amount of RBC transfused, choledochojejunostomy, etc)
18%< 24 hours
50%24 to 48 hours
14%>/= 72 hours
18%Depends (risk-strat)
22 votes • Final results
4
2
We are so excited to gain such an incredible new class of incoming fellows today! Congratulations to each of you on all you have already accomplished. We cannot wait for you to join our Stanford ID family in a few short months!
9
15
9
96
Emily Mui retweeted
✅ Check out this work on persistent VRE bacteremia 🦠🩸➡️🦠🩸 led by the wonderful @FoxEPharmD and @Willeeuhmm with our @StanfordASP @Stanford_ID team @StanDeresinski @Marisa_Holubar @EmilyMui @LinaMengPharmD and Twitter-less Mark Bounthavong. 🥳🎉🙌 bmcinfectdis.biomedcentral.c…
Great work, @FoxEPharmD! “Patients with severe neutropenia, 4 out of 4 positive index blood culture bottles, and lack of source control were more likely to develop persistent VRE bacteremia despite directed antibiotic treatment.” @StanfordASP @Stanford_ID @MDAndersonNews
2
7
18
Interested in risk factors associated with persistent VRE bacteremia? Check this out from our former ID PGY2 @StanfordMed and 🌟 ID PharmD @MDAndersonNews 👏🏽 bmcinfectdis.biomedcentral.c…
Great work, @FoxEPharmD! “Patients with severe neutropenia, 4 out of 4 positive index blood culture bottles, and lack of source control were more likely to develop persistent VRE bacteremia despite directed antibiotic treatment.” @StanfordASP @Stanford_ID @MDAndersonNews
1
1
Emily Mui retweeted
Great work, @FoxEPharmD! “Patients with severe neutropenia, 4 out of 4 positive index blood culture bottles, and lack of source control were more likely to develop persistent VRE bacteremia despite directed antibiotic treatment.” @StanfordASP @Stanford_ID @MDAndersonNews
1
6
3
29
Our very own ID pharmacist and steward Laura Bio @StanfordPedsASP co-moderating her session on New Frontiers in Pediatric ASP @IDWeek2022 #IDweek2022 @PIDSociety
1
5
19
Great session on optimizing antimicrobial stewardship in challenging populations. Check out the shoutout to our very own @Willeeuhmm work in high-risk AML patients 🤒 🧫 👀 @IDWeek2022 @SIDPharm
8
19
Emily Mui retweeted
First time as a speaker @IDWeek2022! Couldn’t have done it without the support of so many mentors. Also great to reconnect w/ colleagues from across the country and meet new friends that are absolutely killing it at their institutions! @StanfordASP @SIDPharm 📸: @HMS_MI – at Washington, DC
8
8
66
#ASP #Pharmacist presence on #infectiousdiseases rounds results in more interventions. Shoutout to the best ASP Pharmacists, Dr. Laura Bio & @LPthePharmD! #idweek2022 @LPCH_IDProgram
2
4
28